Laura Prendergast
Stock Analyst at Raymond James
(0.56)
# 3,825
Out of 4,734 analysts
7
Total ratings
42.86%
Success rate
-27.02%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Laura Prendergast
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
MURA Mural Oncology | Initiates: Strong Buy | $18 | $4.14 | +334.78% | 1 | Oct 4, 2024 | |
NKTX Nkarta | Upgrades: Strong Buy | $16 | $2.44 | +555.74% | 2 | Aug 14, 2024 | |
BDTX Black Diamond Therapeutics | Initiates: Outperform | $20 | $2.24 | +792.86% | 1 | Jul 31, 2024 | |
THRD Third Harmonic Bio | Initiates: Outperform | $18 | $6.00 | +200.00% | 1 | Jun 7, 2024 | |
RVMD Revolution Medicines | Upgrades: Strong Buy | $36 → $48 | $40.16 | +19.52% | 2 | Apr 10, 2024 |
Mural Oncology
Oct 4, 2024
Initiates: Strong Buy
Price Target: $18
Current: $4.14
Upside: +334.78%
Nkarta
Aug 14, 2024
Upgrades: Strong Buy
Price Target: $16
Current: $2.44
Upside: +555.74%
Black Diamond Therapeutics
Jul 31, 2024
Initiates: Outperform
Price Target: $20
Current: $2.24
Upside: +792.86%
Third Harmonic Bio
Jun 7, 2024
Initiates: Outperform
Price Target: $18
Current: $6.00
Upside: +200.00%
Revolution Medicines
Apr 10, 2024
Upgrades: Strong Buy
Price Target: $36 → $48
Current: $40.16
Upside: +19.52%